| Nov 8 |
Pacific Biosciences (PACB) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
|
| Nov 7 |
Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates
|
| Nov 7 |
Pacific Biosciences: Q3 Earnings Snapshot
|
| Nov 7 |
PacBio stock falls 16% post-market after Q3 revenue miss
|
| Nov 7 |
Pacific Biosciences of California Non-GAAP EPS of -$0.17 beats by $0.05, revenue of $40M misses by $1.86M
|
| Nov 7 |
PacBio announces private convertible exchange transaction of 1.50% convertible senior notes due 2028
|
| Nov 7 |
PacBio Announces Third Quarter 2024 Financial Results
|
| Nov 7 |
PacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028
|
| Nov 7 |
PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop
|
| Nov 6 |
Pacific Biosciences of California Q3 2024 Earnings Preview
|
